
HHS withdraws Trump administration policy that limited FDA review of certain Covid-19 tests
CNN
The Biden administration is withdrawing a policy established under the Trump administration that limited the US Food and Drug Administration's review process of certain lab tests, including some Covid-19 tests. The US Department of Health and Human Services announced the withdrawal on Monday.
Last year, the Trump administration determined that the FDA would no longer require premarket review of laboratory-developed tests, known as LDTs. Prior to that determination, laboratories were required to submit applications to develop and use their own Covid-19 tests. But the move to limit that process meant that makers of Covid-19 tests developed by certain labs -- such as Quest Diagnostics, LabCorp or those at academic medical centers -- could distribute their tests without the need to first submit documentation for review by the FDA before they were marketed.

Friday featured yet another drop in the drip-drip-drip of new information from the Jeffrey Epstein files. This time: new pictures released by House Democrats that feature Donald Trump and other powerful people like Bill Clinton, Steve Bannon and Richard Branson, culled from tens of thousands of photos from Epstein’s estate.












